Vanda Pharmaceuticals, Inc. (VNDA)
6.02
-0.06
(-0.99%)
USD |
NASDAQ |
May 19, 09:57
Vanda Pharmaceuticals Research and Development Expense (Quarterly) : 28.44M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| AnaptysBio, Inc. | 33.86M |
| Amgen, Inc. | 1.719B |
| Gossamer Bio, Inc. | 43.07M |
| BridgeBio Pharma, Inc. | 126.64M |
| Geron Corp. | 14.96M |